Screener
TransCode Therapeutics, Inc. RNAZ Q4 2024 earnings
Reported March 28, 2025
EPS-$16.61Beat by $89.32
Revenue estimate$300.0K
EPS estimate-$105.93
Next report
Aug 18, 2026 (In 6 days)Versus estimates
Diluted EPS
FAQ
- When did TransCode Therapeutics, Inc. report Q4 2024 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q4 2024 earnings on March 28, 2025.
- What were TransCode Therapeutics, Inc.'s Q4 2024 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-16.61 for Q4 2024.
- Did TransCode Therapeutics, Inc. beat estimates in Q4 2024?
- EPS beat the consensus estimate of $-105.93 by $89.32.
- Where can I find TransCode Therapeutics, Inc.'s Q4 2024 SEC filings?
- You can read the 8-K earnings release (0001104659-25-027565) directly on SEC EDGAR. The filing index links above go to sec.gov.
